Clinical
RSSArticles
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.
-
Considering More Intensive Blood Pressure Control in the Elderly
In elderly, hypertensive patients, intensive blood pressure (BP) control (systolic BP < 140 mmHg) decreased major adverse cardiovascular events, including cardiovascular mortality and heart failure.
-
Data: Fetal Exposure to HPV Vaccine During Pregnancy Is Safe
Many pregnant women are exposed to the vaccine inadvertently.
-
Syphilis Makes Dangerous Resurgence
Experts say it’s time to act.
-
Telehealth Improves Access to Reproductive Health Education and Services for Rural Adolescents
For adolescents living in rural areas who otherwise would forgo care because of fear of embarrassment, transportation difficulties, and/or confidentiality concerns, using a web app could alleviate many of these concerns.
-
Data Eye Vaginal Bacteria as Trigger for Recurrent UTIs
New research uncovered a trigger of recurrent urinary tract infections — a type of vaginal bacteria that moves into the urinary tract.
-
Discuss Benefits of HPV Vaccine with Parents
Research indicates that concern about sexual activity is declining as a reason parents do not allow their daughters to receive the HPV vaccine.
-
Research Affirms Protective Benefit of Oral Contraceptives
The latest findings from a long-term study indicate that most women who choose to use oral contraceptives do not expose themselves to long-term cancer harms.